Skip to content

Investigating the effect of brown betadine ( povidine iodine7.5%)in preventing SSI

Evaluating the effect of Povidone-Iodine 7.5% as primary skin preparation on prevention of surgical site infections in abdominal hysterectomy cases

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251111067955N1
Enrollment
200
Registered
2025-12-02
Start date
2025-12-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection. Infection following a procedure, not elsewhere classified

Interventions

Intervention 1: In the intervention group, prior to using green betadine (10% povidone iodine), initial prep of the surgical site will be performed with brown betadine (7.5% povidone iodine), and then

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women who are candidates for abdominal hysterectomy and whose surgical indications are determined by a gynecological surgeon Written informed consent to participate in the study Absence of active signs of infection in the body at the time of hospitalization and before surgery dont have Known hypersensitivity to iodine solutions (betadine)

Exclusion criteria

Exclusion criteria: Patient's lack of consent to continue participating in the study at any stage The occurrence of unforeseen complications during or after surgery that require special interventions or changes in treatment course Changing the surgical method during surgery from abdominal hysterectomy to other methods Use of non-standard disinfectant solution or one that differs from research protocols during patient preparation

Design outcomes

Primary

MeasureTime frame
Clinical signs of surgical site infection. Timepoint: 5days,10 days, and one month after surgery. Method of measurement: Observation cheklist based on CDC guidelines for signs of infection.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Jila Agah

Sabzevar University of Medical Sciences

jilaagah@yahoo.com+98 51 4144 6500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026